ArticleJournal of the National Cancer Institute2017

Prediction of Trastuzumab Benefit in HER2-Positive Breast Cancers: Is It in the Intrinsic Subtype?

Jisun Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.